257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business
The Readout Loud
00:00
The Amyloid Hypothesis and Alzheimer's
Meg Urry: How do you think these two trials mean for the amyloid hypothesis? She says there's always this debate about how clinically meaningful these results are and whether or not it really matters to patients. Urry: The take that I've heard from a lot of people in neurology who've been following this for many years is that these are good first steps.
Transcript
Play full episode
